[New, expensive antidiabetics for the treatment of type-2 diabetes--pro].
Müller-Wieland
D
D
Medizinischen Abteilung, Allgemeine Innere Medizin, Gastroenterologie und Stoffwechsel, Endokrinologie und Diabetologie, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099 Hamburg, Germany.
D001786:Blood Glucose / Q000378:metabolism; D003362:Cost-Benefit Analysis / Q000706:statistics & numerical data; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000191:economics*; D017277:Drug Approval / Q000191:economics*; D016527:Drug Costs / Q000706:statistics & numerical data*; D019317:Evidence-Based Medicine; D005858:Germany; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D009313:National Health Programs / Q000191:economics*; D016896:Treatment Outcome
D001786:Blood Glucose; D007004:Hypoglycemic Agents